Factors | Univariate analysis OR (95% CI) | P value | Multivariate analysis OR (95% CI) | P value |
Recurrence | ||||
Age (years): <30 vs ≥30 | 0.344 (0.159 to 0.746) | 0.005 | 0.362 (0.165 to 0.794) | 0.011 |
Atypical endometrial hyperplasia vs endometrial carcinoma | 0.507 (0.247 to 1.024) | 0.079 | ||
Co-morbidity*: yes vs no | 1.556 (0.728 to 3.324) | 0.252 | ||
Obesity: yes vs no | 1.560 (0.871 to 2.794) | 0.125 | ||
Weight loss: <3% vs ≥3% | 2.654 (1.234 to 5.658) | 0.010 | 2.513 (1.162 to 5.434) | 0.019 |
Maintenance therapy: no vs yes | 1.481 (0.591 to 3.741) | 0.400 | ||
Pregnancy | ||||
Age: <35 years vs >35 years | 4.373 (1.427 to 13.406) | 0.010 | 4.589 (1.472 to 14.307) | 0.009 |
Co-morbidity: yes vs no | 1.194 (0.513 to 2.782) | 0.681 | ||
Obesity: no vs yes | 2.688 (1.284 to 6.203) | 0.018 | 2.820 (1.215 to 6.545) | 0.012 |
Atypical endometrial hyperplasia vs endometrial carcinoma | 1.364 (0.604 to 3.079) | 0.455 | ||
Weight loss: ≥3% vs <3% | 1.676 (0.800 to 3.512) | 0.758 | ||
In vitro fertilization and embryo transfer: yes vs no | 2.231 (1.031 to 4.824) | 0.037 | 2.098 (0.919 to 4.790) | 0.055 |
*Combined with polycystic ovary syndrome and/or endometriosis.